ABVC BioPharma, Inc. (ABVC)
0.86
-0.02
(-2.27%)
USD |
NASDAQ |
Nov 20, 16:00
0.86
0.00 (0.00%)
After-Hours: 19:36
ABVC BioPharma Gross Profit (TTM) : -0.4841M for Sept. 30, 2026
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | -0.4841M |
| June 30, 2026 | -0.4917M |
| March 31, 2026 | -0.483M |
| December 31, 2025 | -0.5048M |
| September 30, 2025 | -0.4681M |
| June 30, 2025 | -0.0895M |
| March 31, 2025 | -0.006M |
| December 31, 2024 | 0.0063M |
| September 30, 2024 | 0.039M |
| June 30, 2024 | -0.2648M |
| March 31, 2024 | -0.3343M |
| December 31, 2023 | -0.1711M |
| September 30, 2023 | 0.2906M |
| June 30, 2023 | 0.3369M |
| March 31, 2023 | 0.7028M |
| December 31, 2022 | 0.6596M |
| September 30, 2022 | 0.4382M |
| June 30, 2022 | 0.441M |
| March 31, 2022 | 0.4009M |
| September 30, 2021 | 0.4361M |
| June 30, 2021 | 0.4385M |
| March 31, 2021 | 0.6225M |
| December 31, 2020 | 0.4272M |
| September 30, 2020 | 0.46M |
| June 30, 2020 | 0.5425M |
| Date | Value |
|---|---|
| March 31, 2020 | 0.4933M |
| December 31, 2019 | 0.6265M |
| September 30, 2019 | 0.3504M |
| June 30, 2019 | 0.1594M |
| March 31, 2019 | -0.0137M |
| December 31, 2018 | -0.2219M |
| September 30, 2018 | -0.0321M |
| June 30, 2018 | -0.0218M |
| March 31, 2018 | -0.0114M |
| December 31, 2017 | 0.00 |
| September 30, 2017 | 0.00 |
| June 30, 2017 | 0.00 |
| December 31, 2016 | 0.00 |
| September 30, 2016 | 0.00 |
| June 30, 2016 | 0.0008M |
| March 31, 2016 | 0.0008M |
| December 31, 2015 | 0.0028M |
| September 30, 2015 | 0.0028M |
| June 30, 2015 | 0.002M |
| March 31, 2015 | 0.002M |
| December 31, 2014 | 0.00 |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | -0.008M |
| December 31, 2013 | -0.008M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (TTM) Benchmarks
| T2 Biosystems, Inc. | -- |
| Anika Therapeutics, Inc. | 78.26M |
| Perspective Therapeutics, Inc. | -4.251M |
| MiMedx Group, Inc. | 233.73M |
| Abbott Laboratories | 25.24B |